[China Cord Blood Corporation Reports Second Quarter and First Half Fiscal 2011 Financial Results 29.4% Increase in 2Q11 Revenue 24.6% Increase in 2Q11 Net Income Attributable to Shareholders Conference Call to be Held at 8 am ET November 24, 2010 HONG KONG, China, November 24, 2010 -- China Cord Blood Corporation (NYSE: CO) (“CCBC” or “the Company”), China’s leading provider]
[Chinard Bloodrporation Reports Second Quarter and First Half Fiscal 2011 Financial Results 29.4%rease in 2Q11 Revenue 24.6%rease in 2Q11 Netome Attributable to Shareholdersnferencell to be Held at 8 am ET November 24, 2010 HONG KONG, China, November 24, 2010 -- Chinard Bloodrporation (NYSE:) (CCBC or thempany), Chinas leading provider ofrd bloodllection, laboratory testing, hematopoietic stem]
[Chinard Bloodrporation Reports Second Quarter and First Half Fiscal 2011 Financial Results 29.4%rease in 2Q11 Revenue 24.6%rease in 2Q11 Netome Attributable to Shareholdersnferencell to be Held at 8 am ET November 24, 2010 HONG KONG, China, November 24, 2010 -- Chinard Bloodrporation (NYSE:) (CCBC or thempany), Chinas leading provider ofrd bloodllection, laboratory testing, hematopoietic stem]
[(Name of Issuer) Ordinary Shares, $0.0001 par value G21107100 (CUSIP Number) November 19, 2010 (Date of Event Which Requires Filing of this Statement) o Rule 13d-1(b) þ Rule 13d-1(c) o Rule 13d-1(d) *The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and]
[(Name of Issuer) Ordinary Shares, $0.0001 par value G21107100 (CUSIP Number) November 19, 2010 (Date of Event Which Requires Filing of this Statement) o Rule 13d-1(b) þ Rule 13d-1(c) o Rule 13d-1(d) *The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and]
[SCHEDULE TO (Amendment No. 1) (Rule 14d-100) Tender Offer Statement under Section 14(d)(1) or 13(e)(1) CHINA CORD BLOOD CORPORATION (Name of Subject Company (Issuer) and Name of Filing Person (Issuer)) (Title of Class of Securities) KYG211071181 ) Albert Chen +852 3605 8180 albert.chen@chinacordbloodcorp.com 48th Floor, Bank of China Tower 1 Garden Road Central, Hong Kong S.A.R. (Name, Address and Telephone]
[(Name of Issuer) Ordinary Shares, $0.0001 par value G21107100 (CUSIP Number) November 19, 2010 (Date of Event Which Requires Filing of this Statement) o Rule 13d-1(b) Rule 13d-1(c) o Rule 13d-1(d) *The remainder of thisver page shall be filled out for a reporting person's initial filing on this form with respect to the subject class]
[(Name of Issuer) Ordinary Shares, $0.0001 par value G21107100 (CUSIP Number) November 19, 2010 (Date of Event Which Requires Filing of this Statement) o Rule 13d-1(b) Rule 13d-1(c) o Rule 13d-1(d) *The remainder of thisver page shall be filled out for a reporting person's initial filing on this form with respect to the subject class]
[SCHEDULE TO (Amendment No. 1) (Rule 14d-100) Tender Offer Statement under Section14(d)(1) or 13(e)(1) CHINARD BLOODRPORATION (Name of Subjectmpany (Issuer) and Name of Filing Person (Issuer)) (Title of Class of Securities)G211071181 )bert Chen +852 3605 8180bert.chen@chinacordbloodcorp.com 48th Floor, Bank of China Tower 1 Garden Road]
[SCHEDULE TO (Rule 14d-100) Tender Offer Statement under Section 14(d)(1) or 13(e)(1) CHINA CORD BLOOD CORPORATION (Name of Subject Company (Issuer) and Name of Filing Person (Issuer)) (Title of Class of Securities) KYG211071181 ) Albert Chen +852 3605 8180 albert.chen@chinacordbloodcorp.com 48th Floor, Bank of China Tower 1 Garden Road Central, Hong Kong S.A.R. (Name, Address and Telephone Number of Person] [OFFER LETTER TO PURCHASE ORDINARY SHARES OF CHINA CORD BLOOD CORPORATION NOVEMBER 10, 2010 The Offer will commence on November 10, 2010 (the date the materials relating to the Offer are first sent to the holders) and end on the Expiration Date. IMPORTANT PROCEDURES · · · ·] [LETTER OF TRANSMITTAL OF CHINA CORD BLOOD CORPORATION NOVEMBER 10, 2010 THE OFFER AND WITHDRAWAL EXPIRE AT 5:00 P.M., U.S. EASTERN TIME ON THE NIGHT OF DECEMBER 10, 2010 UNLESS THE OFFER IS EXTENDED The Depositary for the Offer is: Continental Stock Transfer & Trust Company BY MAIL, HAND OR OVERNIGHT DELIVERY: CONTINENTAL STOCK TRANSFER & TRUST COMPANY 17 BATTERY] [CHINA CORD BLOOD CORPORATION This Notice of Guaranteed Delivery, or one substantially in the form hereof, must be used to accept the Offer (as defined below) if: • Depositary” ) prior to the Expiration Date, or • Time will not permit all required documents, including a properly completed and duly executed Letter of Transmittal (or a manually signed facsimile of] [Offer Letter to Exchange for Shares by CHINA CORD BLOOD CORPORATION of THE TENDER OFFER AND WITHDRAWAL RIGHTS WILL EXPIRE AT 5:00 P.M., NEW YORK CITY TIME, ON December 10, 2010, UNLESS THE TENDER OFFER IS EXTENDED. November 10, 2010 To Brokers, Dealers, Commercial Banks, Trust Companies and Other Nominees: Offer Letter Offer Company Shares Offer Period Expiration Date Enclosed] [Offer Letter to Exchange for Shares by CHINA CORD BLOOD CORPORATION of THE TENDER OFFER AND WITHDRAWAL RIGHTS WILL EXPIRE AT 5:00 P.M., NEW YORK CITY TIME, ON DECEMBER 10, 2010, UNLESS THE TENDER OFFER IS EXTENDED. To Our Clients: Offer Letter Offer Company Shares Offer Period Expiration Date Enclosed for your consideration are the Offer Letter, dated November 10,] [Details of Exchange Offer Provided HONG KONG, China, November 10 - China Cord Blood Corporation th Ms. Ting Zheng concluded, “The past nine months marked several important milestones in our corporate development history. We are excited as our operations in Beijing and Guangdong continue to bear fruits, and our nationwide roll-up strategy also yields astonishing achievements. In conjunction with our] [FORM OF LOCK-UP AGREEMENT THIS LOCK-UP AGREEMENT Agreement Company Securityholder WITNESSETH: WHEREAS, Exchange Offer Ordinary Shares WHEREAS, Securities WHEREAS, NOW, THEREFORE, Certain Covenants 1. Lock-Up provided however 1.1 Tender of Securities 1.2 Public Announcement 1.3 Disclosure SEC provided however 1.4 Restriction on changes to terms of Exchange Offer 1.5 2. Ownership Liens 2.1 2 Authorization 2.2 No Violation 2.3 The]
